ライフサイエンスコーパス: MAC

1 MAC adopts a 'split-washer' configuration, in contrast t

2 MAC also influences the outcomes of cardiac surgery and

3 MAC and AEC were exposed to different amounts of Mn3O4 (

4 MAC directly lyses pathogens by a 'multi-hit' mechanism;

5 MAC was present in 1,149 participants (20.4%).

6 MACs and OCs undergo highly similar 5hmC and 5mC changes

7 MACs from patients were cultured with and without 10 nM

8 remaining patients were categorized into (1) MAC and (2) elective intubation for the procedure (elect

9 en of the lymphatic endothelium in an ICAM-1/MAC-1-dependent manner.

10 Sensitivity of the rapid tests and 3 MAC-ELISAs was <50%, and thus these assays are not recom

11 ters against lipid antigens extracted from a MAC strain.

12 rect analysis of the relevant forces, that a MAC balance can be achieved when the viscosity is reduce

13 s of microbe-microbe proximity reveal that a MAC-deficient diet alters monophyletic spatial clusterin

14 closed head injury in mice induced abundant MAC deposition in the brain.

15 after RIC and 25% (95% CI, 15% to 36%) after MAC ( P = .29).

16 II to IV was 32.3% after RIC and 37.5% after MAC ( P = .35).

17 disease was 61.6% after RIC and 64.7% after MAC ( P = .76).

18 a retrospective cohort study evaluating all MAC isolates obtained from pulmonary specimens at our in

19 Although MAC was initially thought to be an age-related degenerat

20 with increased iC3b/C3b binding avidity and MAC inhibitory activity.

21 South African Medical Research Council, and MAC AIDS Fund.

22 in the differential diagnosis of lip MEL and MAC.

23 obabilities of overall survival with RIC and MAC regimens were 45% and 48%, respectively (P = .99).

24 tumour necrosis factor alpha (TNFalpha) and MAC-conditioned media.

25 The source code, binaries for MS Windows and MAC OS X as well as test LC-MS data are available for do

26 Embedded converter machines and MACs with improved geometry were designed and fabricated

27 an MAC-PP, the highest AFS grade and no anti-MAC treatment were correlated with radiographic progress

28 ade; if these risk factors are present, anti-MAC treatment should be seriously considered.

29 logical persistence of MAC-LD was defined as MAC-PP exceeding 1 year, in contrast with the negative-c

30 y capture enzyme-linked immunosorbent assay (MAC-ELISA) followed by supplemental testing of specimens

31 y capture enzyme-linked immunosorbent assay (MAC-ELISA) for screening, followed by a confirmatory pla

32 y-capture enzyme-linked immunosorbent assay (MAC-ELISA).

33 y capture enzyme linked immunosorbent assay (MAC-ELISA).

34 capture enzyme-linked immunosorbent assays (MAC-ELISAs), and indirect immunofluorescence tests.

35 -capture enzyme-linked immunosorbent assays (MAC/GAC-ELISAs) targeted at envelope protein (E) of deng

36 tone modification and expression patterns at MAC-/OC-specific genes.

37 rential histone modification changes between MACs and OCs.

38 acquisition of differential features between MACs and OCs also depends on TET2/TDG.

39 e SETD1A is differentially recruited between MACs and OCs in a TET2-dependent manner.

40 d a C6 antisense oligonucleotide that blocks MAC formation by inhibiting C6, and we compared its ther

41 lar to that seen with CD4(+) T cells in both MAC and AGM.

42 ent-naive noncavitary nodular bronchiectatic MAC lung disease.

43 ents with noncavitary nodular bronchiectatic MAC lung disease.

44 nregulation of IP-10 and changes in ED:EI by MAC regulation of eNOS in endothelial cells.

45 Calcitriol reduced IP-10 expression by MACs (p<0.0006), and blockade of IP-10 restored the angi

46 endosome-based signaling complex induced by MACs to stabilize NIK.

47 ne-mediated activation, NIK stabilization by MACs did not involve cIAP2 or TRAF3.

48 orporating K[nido-7-CH3(CH2)15-7,8-C2B9H11] (MAC) in the bilayer membrane while encapsulating the hyd

49 Mitral annulus calcification (MAC) is a chronic, degenerative process in the fibrous b

50 stin-specific medial arterial calcification (MAC) is an arterial disease commonly referred as Monckeb

51 Mitral annular calcium (MAC), commonly identified by cardiac imaging, is associa

52 orce, rotational force, and buoyancy (called MAC balance for Magnetic, Archimedean, Coriolis) with on

53 h a sensitive microfluidic antibody capture (MAC) chip.

54 and involves the methylene alkoxy carbamate (MAC) self-immolative unit.

55 Microbiota-accessible carbohydrates (MACs) found in dietary fibre have a crucial involvement

56 tion of microbiota-accessible carbohydrates (MACs) from the diet results in thinner mucus in the dist

57 is of Chemotherapy in Nasopharynx Carcinoma (MAC-NPC) collaborative group to assess the addition of c

58 outcomes between monitored anesthesia care (MAC) and general anesthesia (GA) in patients presenting

59 ND & AIMS: Use of monitored anesthesia care (MAC) for gastrointestinal endoscopy has increased in the

60 Myeloid angiogenic cells (MACs) promote angiogenesis to restore damaged vessels.

61 Myeloid angiogenic cells (MACs), derived from circulating monocytes, augment vascu

62 (TRB) and Multiple Atmospheric Circulation (MAC) to explore the mechanism of MAC driving the drying

63 varying degrees of virulence and classifying MAC isolates into distinct species aids in identifying w

64 microphthalmia, anophthalmia, and coloboma (MAC) and inherited retinal dystrophies, collectively rep

65 driving the drying in TRB, through comparing MAC between abundant and scarce precipitation years.

66 ormed a phase III randomized trial comparing MAC with RIC in patients with acute myeloid leukemia or

67 he abundance of the membrane attack complex (MAC) and performed immunofluorescence studies on eyes fr

68 ent activation, the membrane attack complex (MAC) assembles from fluid-phase proteins to form pores i

69 designed to inhibit membrane attack complex (MAC) assembly at sites of C3b/iC3b deposition.

70 interacted with the membrane attack complex (MAC) components C5, C7, and C9, thereby blocking the ass

71 Terminal complement membrane attack complex (MAC) formation is induced initially by C5b, followed by

72 ed by inhibition of membrane attack complex (MAC) formation.

73 The membrane attack complex (MAC) of the complement system is detected in the traumat

74 C7 protein, soluble membrane attack complex (MAC), and IL-1beta expression compared with the donor C7

75 sential role in the membrane attack complex (MAC), which forms a lethal pore on the cellular surface

76 paid to that of the membrane attack complex (MAC).

77 The membrane attack complex (MAC)/perforin-like protein complement component 9 (C9) i

78 stent growth of Mycobacterium avium complex (MAC) in the lungs indicates continuous infection in MAC

79 bronchiectatic Mycobacterium avium complex (MAC) lung disease, supporting data are limited.

80 mycobacterial (Mycobacterium avium complex [MAC] or Mycobacterium abscessus) disease.

81 Complement membrane attack complexes (MACs) promote inflammatory functions in endothelial cell

82 rface assembly of membrane attack complexes (MACs), which promote inflammation by causing aberrant si

83 not exceed maximum acceptable concentration (MAC) of 0.003mgkg(-1)bw(-1)day(-1) through daily consump

84 regulatory maximum allowable concentrations (MACs), with the exception of the higher molecular weight

85 Within mobile air-conditioning (MAC), the largest RAC sector and most significant UK sou

86 atients received myeloablative conditioning (MAC), and 21 patients received reduced-intensity conditi

87 es compared with myeloablative conditioning (MAC), making RIC-HSCT a viable option for older patients

88 S) compared with myeloablative conditioning (MAC).

89 (RIC) instead of myeloablative conditioning (MAC); however, the biology underlying this treatment rem

90 those receiving myeloablative-conditioning (MAC) regimens.

91 cently reconstituted minimal actin cortices (MACs) and here advanced our assay to investigate effects

92 whereby we specify a maximum allowable cost (MAC) per ton of CO2 stored, a priori, and determine the

93 The reaction utilizes a masked acyl cyanide (MAC) reagent, which enables the one-pot preparation of a

94 Masked acyl cyanide (MAC) reagents are shown to be effective umpolung synthon

95 With dermoscopy, MAC were correctly classified as benign in 13 of 16 case

96 s, the draped pattern-a previously described MAC RCM feature-was identified in all cases.

97 (CDC) Zika MAC-ELISA, the InBios ZIKV Detect MAC-ELISA, and the Euroimmun anti-Zika Virus IgM ELISA.

98 of missing taxa in combination with dietary MAC consumption.

99 involve strategies that incorporate dietary MACs as well as taxa not currently present in the Wester

100 overable after the reintroduction of dietary MACs.

101 at taxa driven to low abundance when dietary MACs are scarce are inefficiently transferred to the nex

102 es continuous infection in MAC lung disease (MAC-LD), but its clinical significance has not been inve

103 he clinical courses associated with distinct MAC species.

104 he modified Rankin scale score distribution (MAC: OR, 1.52; 95% CI, 0.80-2.90; P = .19).

105 D receptor was transiently expressed during MAC differentiation and that in vitro, calcitriol increa

106 ti-NS1 antibodies and compare it with anti-E MAC/GAC-ELISA.

107 We find no evidence that either MAC or PAC are associated with LTL in offspring across t

108 imize an IgM and IgG antibody-capture ELISA (MAC/GAC-ELISA) to detect anti-NS1 antibodies and compare

109 ence of bacteria-induced metamorphic events: MACs induce larval settlement; then, particular properti

110 tern, and positive AFS had an OR of 17.7 for MAC-PP, and those with >/=2 of the factors had a 4.5-fol

111 tivated Akt to MAC(+) endosomes, but not for MAC internalization or for Akt activation.

112 the factors had a 4.5-fold increased OR for MAC-PP relative to the comparison group.

113 dictors of persistent culture-positivity for MAC (MAC-PP) and its impact on radiographic deterioratio

114 Patients who converted from MAC to GA during the procedure were included in the MAC

115 re frequent and significantly different from MAC: epidermal disarray; pagetoid infiltration of dendri

116 tures that assist in distinguishing MEL from MAC using dermoscopy and RCM.

117 The conversion rate from MAC to GA was 13% (n = 8).

118 C9 subunits can be recruited to the growing MAC subsequent to membrane insertion.

119 Sixty-three patients had MAC (36%) and 113 patients had GA (64%).

120 electron cryo-microscopy structure of human MAC at subnanometre resolution.

121 a gene expression signature that implicates MAC as a driver of tumor progression.

122 In MAC elevated ROS levels, decreased metabolic activity an

123 its impact on radiographic deterioration in MAC-LD.

124 ection levels were similar to those found in MAC pDC.

125 provement was associated with an increase in MAC number and function.

126 the lungs indicates continuous infection in MAC lung disease (MAC-LD), but its clinical significance

127 Nucleosome occupancy in MAC and MIC are nonetheless highly correlated with each

128 terminants promote nucleosome positioning in MAC.

129 The improved angiogenic capacity in MACs might be mediated via downregulation of IP-10 and c

130 V infection, we show that the CDC and InBios MAC-ELISAs perform comparably to each other, with positi

131 immun ZIKV ELISA to either the CDC or InBios MAC-ELISAs resulted in positive agreement, negative agre

132 Indeed, MAC is associated with an increased incidence of cardiov

133 have described the structures of individual MAC components and subcomplexes; however, the molecular

134 (85%) and serum levels (90%), and inhibited MAC deposition in the injured brain (91-96%).

135 CD59-2a-CRIg inhibited MAC formation and prevented complement-mediated lysis in

136 CD59-2a-CRIg inhibited MAC-induced inflammasome activation and IL-1beta product

137 Moreover, PGK significantly inhibited MAC deposition via both the classical and alternative pa

138 ulator CD59 to the RPE cell surface inhibits MAC formation.

139 increased differentiation of monocytes into MACs in both SLE and in a model using the prototypic SLE

140 hich C7 defends against bacteria may involve MAC formation, leading to NLRP3 inflammasome activation

141 Another possibility involves MAC waves, which arise from the interplay between magnet

142 investigated mechanisms crucial for limiting MAC assembly and preserving cellular integrity in the RP

143 es in the microbiota of mice consuming a low-MAC diet and harbouring a human microbiota are largely r

144 However, over several generations, a low-MAC diet results in a progressive loss of diversity, whi

145 rs of persistent culture-positivity for MAC (MAC-PP) and its impact on radiographic deterioration in

146 an immunodeficiency virus (SIV) in macaques (MAC) lead to chronic inflammation and AIDS.

147 through the presence of somatic macronuclei (MAC) and germline micronuclei (MIC).

148 anscriptionally active somatic macronucleus (MAC) and the transcriptionally silent germ-line micronuc

149 ty-were studied in rat alveolar macrophages (MAC) and epithelial cells (AEC).

150 effectors of innate immunity as macrophages (MACs) and bone remodelling as osteoclasts (OCs).

151 Benign melanotic macules (MAC) are the most frequent cause of lip pigmentation and

152 We test for maternal (MAC) and paternal age at conception effects on offspring

153 transcriptionally active genes in the mature MAC genome, making these ciliates model organisms to stu

154 The median measured MAC at lambda = 660 nm for smoldering oak particles was

155 ar, Baldcypress, and Blue spruce) had median MAC values ranging from 1.4 x 10(-2) m(2) g(-1) to 7.9 x

156 Methyl vinyl ketone (MVK) and methacrolein (MAC) are key oxidation products (iox) of isoprene, the m

157 ambient iox (from 0 to 6 ppbv of a 1:1 = MVK/MAC mixture) in all the investigated species, indicating

158 al myeloid differentiation processes, namely MAC and OC differentiation.

159 tion, C9 assembles directly onto the nascent MAC from solution.

160 isplacement conversion efficiency of the new MACs over the existing ones was demonstrated.

161 fg (500 nm </= mobility diameter </=950 nm), MAC values in parentheses are the 16(th) and 84(th) perc

162 mbining the use of multiantigen VLP- and NS1-MAC-ELISAs was developed and can be practically applied

163 erall assay performances of the VLP- and NS1-MAC-ELISAs.

164 ural protein 1 (NS1)-specific MAC-ELISA (NS1-MAC-ELISA) on archived acute-phase serum specimens from

165 ed positive-to-negative (P/N) ratios for NS1-MAC/GAC-ELISAs after the depletion of anti-prM/E antibod

166 When the NS1-MAC-ELISA was used to confirm positive results in the VL

167 along with naive sera, were subjected to NS1-MAC/GAC-ELISAs before or after depletion of anti-prM/E a

168 Consistent with these in vitro observations, MAC internalization occurred in human coronary ECs in vi

169 entives to promote appropriate allocation of MAC based on clinically meaningful patient factors.

170 Using network analysis of MAC-responsive expression changes, we demonstrate a clus

171 toxin C5a and C5b, an essential component of MAC.

172 nsistent, clinically relevant description of MAC on the basis of contemporary imaging.

173 olism, also contribute to the development of MAC.

174 mechanisms contributing to the formation of MAC and the clinical implications of this disease entity

175 The biological functionalities of MAC has been previously investigated by using either the

176 idence, to our knowledge, that inhibition of MAC formation in otherwise complement-sufficient animals

177 nt opsonization, site-targeted inhibition of MAC should be considered to promote recovery postneurotr

178 cking the assembly and membrane insertion of MAC resulting in significant inhibition of the hemolytic

179 However, the molecular mechanism of MAC assembly remains to be understood.

180 irculation (MAC) to explore the mechanism of MAC driving the drying in TRB, through comparing MAC bet

181 Microbiological persistence of MAC-LD was defined as MAC-PP exceeding 1 year, in contra

182 The predictors of MAC-PP are low BMI, NB pattern, and high AFS grade; if t

183 Independent predictors of MAC-PP were low body mass index (BMI), radiographic nodu

184 ignificantly associated with the presence of MAC (odds ratio [OR] per triglyceride GRS unit: 1.73; 95

185 e levels was associated with the presence of MAC, a risk factor for clinically significant mitral val

186 ma lipids is associated with the presence of MAC.

187 The adjusted rate of MAC use in the VHA increased 17% per year (odds ratio fo

188 (IES) are excised, followed by rejoining of MAC-destined sequences, while fragmentation occurs at co

189 ite its frequency, the clinical relevance of MAC is grossly underappreciated.

190 should focus on better defining the role of MAC and facility and organizational factors that affect

191 A series of MAC beta-glucuronide model constructs were prepared to e

192 /-), which is associated with suppression of MAC-mediated inflammasome activation in mC9(-/-).

193 and promote CDC with a very low threshold of MAC binding, thus providing additional insight into thei

194 ects had the greatest effect on the trend of MAC use.

195 These data support the use of MAC as the standard of care for fit patients with acute

196 investigated factors associated with use of MAC in an integrated health care delivery system with a

197 VHA use of MAC was associated with patient-level factors that inclu

198 ity factors were also associated with use of MAC, although again the magnitude of these associations

199 ominent factor influencing increasing use of MAC.

200 ctors are only weakly associated with use of MAC.

201 of IP-10 restored the angiogenic capacity of MACs from patients with SLE.

202 ol also augmented the angiogenic capacity of MACs via the down-regulation of CXCL-10.

203 ad this response required internalization of MACs in a clathrin-, AP2-, and dynamin-dependent manner

204 eficient patients had an increased number of MACs compared with controls (p=0.04) but impaired migrat

205 l settlement; then, particular properties of MACs encoded by a specific locus in P. luteoviolacea ini

206 A further type of MACs with conversion ability, viz.

207 use of ruxolitinib pretransplant, optimizing MAC to decrease toxicity, and use of posttransplant JAK2

208 C9 to the C5b-8 complex forms the C5b-9 (or MAC).

209 g either the mice deficient in C5 and C6, or MAC's regulator CD59.

210 A novel approach to perform MAC/GAC-ELISAs for NS1 antibody detection was successful

211 RA-MAC cases also had a better presenting and final visual

212 RA-MAC is a reasonable alternative to GA for the repair of

213 RA-MAC was selected more often for Zone 1 and Zone 2 injuri

214 ar block) with Monitored Anesthesia Care (RA-MAC) or General Anesthesia (GA) for open globe injury re

215 ries, there are equal selection ratio for RA-MAC and GA.

216 Open globe injuries repaired under RA-MAC had significantly shorter wound length (p<0.001), mo

217 Globe injury repair was performed using RA-MAC in 351/448 (78%) patients and general anesthesia in

218 Due to antibody cross-reactivity, MAC-ELISA-positive samples may be confirmed with a time-

219 ts pre-HCT were randomly assigned to receive MAC (n = 135) or RIC (n = 137) followed by HCT from HLA-

220 to sites of injury and significantly reduced MAC deposition, microglial accumulation, mitochondrial s

221 ystemic toxicity in patients with refractory MAC lung disease.

222 ) with a myeloablative conditioning regimen (MAC) before allogeneic transplantation in patients with

223 ad a mass-specific absorption cross section (MAC) of 7.89 +/- 0.25 m(2) g(-1) at lambda = 550 nm and

224 as mass-specific absorption cross sections (MAC).

225 Interestingly, PGK bound several MAC proteins simultaneously.

226 m of vitamin D (calcitriol) restored the SLE MAC phenotype towards that of healthy subjects with redu

227 ther enhanced by calcitriol treatment of SLE MACs.

228 We observed that SLE MACs are dysfunctional and secrete pro-inflammatory cyto

229 can be isolated by FACS or magnetic sorting (MAC) which give rise to dopamine neurons expressing TH a

230 particle therapy to reverse elastin-specific MAC and circumvent side effects associated with systemic

231 nous NP injections reversed elastin-specific MAC in rats after four injections over a 2-week period.

232 anti-nonstructural protein 1 (NS1)-specific MAC-ELISA (NS1-MAC-ELISA) on archived acute-phase serum

233 rM/E containing virus-like particle-specific MAC-ELISA (VLP-MAC-ELISA).

234 Our findings suggest that specific MAC species have varying degrees of virulence and classi

235 rapy for acute posterior circulation stroke, MAC is feasible and appears to be as safe and effective

236 morphosis-associated contractile structures (MACs).

237 y a 'multi-hit' mechanism; however, sublytic MAC pores on host cells activate signalling pathways.

238 ds light on the mechanisms by which sublytic MAC causes tumor cell responses and exposes a gene expre

239 Other than MAC-PP, the highest AFS grade and no anti-MAC treatment

240 Here, we demonstrate that MAC features well-positioned nucleosomes downstream of t

241 The results show that MAC affects both the magnitude and spatial distribution

242 Here I show that MAC waves provide a good description of time-dependent z

243 We conclude that MACs activate noncanonical NF-kappaB by forming a novel

244 ring five developmental stages revealed that MACs induce the regulation of groups of genes important

245 We also show that MACs were able to positively modulate eNOS expression in

246 All the MAC model compounds efficiently released alcohol drug su

247 rstanding of the roles of complement and the MAC in tumor development and progression, which in turn

248 To assess the MAC technology for ADCs, the potent microtubule-disrupti

249 dies on eyes from 117 donors to evaluate the MAC in aging, early AMD, and advanced AMD.

250 rs (interquartile range, 60-75 years) in the MAC group vs 67 years (interquartile range, 55.5-78.5 ye

251 Fifty-four percent of the patients in the MAC group were men vs 41% in the GA group (P = .44).

252 GA during the procedure were included in the MAC group.

253 a structural model of C9, as present in the MAC, hints at their putative roles in pore formation or

254 6 patients with MAC-LD, 75 (60%) were in the MAC-PP group; these patients had a higher proportion of

255 Conjugation of the MAC beta-glucuronide AE drug linker to the anti-CD30 ant

256 However, a significant revision of the MAC servicing rate, coupled with a reassessment of non-R

257 plication in TBI patients, inhibition of the MAC should be considered to reduce posttraumatic neurolo

258 n symmetric and asymmetric components of the MAC underpin a molecular basis for pore formation and su

259 mponent 9 (C9) is the major component of the MAC, a multi-protein complex that forms pores in the mem

260 Three of the MAC-ELISA kits and 1 indirect immunofluorescence kit had

261 soluble form of the poly-C9 component of the MAC.

262 ear more or less attractive depending on the MAC scenario considered.

263 These studies validate the MAC self-immolative unit for alcohol-containing payloads

264 In vitro, the MAC significantly triggered NLRP3 inflammasome activatio

265 design trebled the energy absorption of the MACs.

266 se-separated lipid mono- and bilayers to the MACs.

267 required for recruitment of activated Akt to MAC(+) endosomes, but not for MAC internalization or for

268 and SM pDC were found to be, in contrast to MAC pDC, predominantly negative for CCR5.

269 ation in mediating the observed responses to MAC exposure.

270 ree survival and overall survival similar to MAC in patients with MDS or secondary acute myeloid leuk

271 Media from calcitriol-treated MACs more strongly attenuated TNFalpha-mediated downregu

272 Media from calcitriol-treated MACs significantly increased angiogenesis compared with

273 Using two MAC mutations that block P. luteoviolacea from inducing

274 express extremely low levels of CD4, unlike MAC and human pDC.

275 aortic endothelial cells than did untreated MACs from patients with SLE (p=0.01).

276 creased angiogenesis compared with untreated MACs (p=0.01).

277 se of high relapse incidence with RIC versus MAC (48.3%; 95% CI, 39.6% to 56.4% and 13.5%; 95% CI, 8.

278 und between the newly developed NS1- and VLP-MAC/GAC-ELISAs.

279 virus-like particle-specific MAC-ELISA (VLP-MAC-ELISA).

280 used to confirm positive results in the VLP-MAC-ELISA, the specificity of serodiagnosis, especially

281 ts, the triglyceride GRS was associated with MAC (OR per triglyceride GRS unit: 1.79; 95% CI: 1.32 to

282 sterol GRS was significantly associated with MAC.

283 ower in patients receiving RIC compared with MAC and in patients having progression compared with pat

284 r TRM but higher relapse rates compared with MAC, with a statistically significant advantage in RFS w

285 gnificantly prolonged survival compared with MAC-transplanted recipients (TBI of 850 cGy plus cycloph

286 ls was about the double in MEL compared with MAC.

287 tly in patients without cystic fibrosis with MAC and was sustained 1 year after LAI.

288 ions of lipid genetic risk scores (GRS) with MAC in 3 large patient cohorts: the Framingham Health St

289 Conclusion OS was higher with MAC, but this was not statistically significant.

290 SD] age, 34.5 [6.1] years), 16 patients with MAC (mean [SD] age, 49.6 [17.9] years), and 5 patients w

291 ypes, and Group 2 consisted of patients with MAC and MEL; RCM and dermoscopy were used for lips analy

292 Patients with MAC-LD at multiple medical centers from 2011 to 2016 wer

293 Microbiological persistence in patients with MAC-LD is not uncommon and leads to an increased risk of

294 Among 126 patients with MAC-LD, 75 (60%) were in the MAC-PP group; these patient

295 in all patients with MEL and 5 patients with MAC.

296 p, patients who underwent the procedure with MAC had similar rates of successful reperfusion, good cl

297 y using multilevel logistic regression, with MAC use modeled as a function of procedure year, patient

298 tistically significant advantage in RFS with MAC.

299 rial that compared a busulfan-based RIC with MAC in patients with MDS or secondary acute myeloid leuk

300 or Disease Control and Prevention (CDC) Zika MAC-ELISA, the InBios ZIKV Detect MAC-ELISA, and the Eur